EIF4A1 and neoplasm: This is an interesting finding as targeting of eIF4A have been reported to sensitize the tumor cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis or break TRAIL resistance in tumor cells (61–66).